Chemistry: molecular biology and microbiology – Vector – per se
Patent
1997-03-05
2000-06-06
Guzo, David
Chemistry: molecular biology and microbiology
Vector, per se
536 235, 536 2351, 536 2352, C12N 1586
Patent
active
060717424
ABSTRACT:
The present invention is drawn to the use of artificially attenuated Coxsackievirus B3 cardiotropic virus vectors as efficient gene transfer vectors to deliver immunomodulatory proteins and/or antigenic epitopes in transient infections to aid in preventing, ameliorating, and/or ablating infectious viral heart disease and reducing, or ablating entirely, heart transplant rejection. Additionally, other organs or tissues may be targeted with specific picornaviruses. An attenuated CVB3 viral vector able to express a cytokine is provided. This cytokine-expressing viral vector is able to deliver the cytokine to a target tissue and reduce disease symptoms
REFERENCES:
Verma et al., Nature, vol. 389, pp. 239-242, Sep. 18, 1997.
Leslie et al., Clinical Microbiology Reviews, vol. 2, No. 2, Apr. 1989, pp. 191-203.
M.B.A. Oldstone, Virology, vol. 234, 1997, pp. 179-185.
Cohen, Science, vol. 265, Sep. 2, 1994, pp. 1371-1373.
Zhang et al., American Journal of Pathology, vol. 150, No. 6, Jun. 1997, pp. 2197-2207.
Orkin et al., "Report and Recommendations of the Panel to Assess the NIH Investment in Research on Gene Therapy", Dec. 7, 1995.
Chapman Nora M.
Kolbeck Peter
Malone James
Tracy Steven M.
Board of Regents of the University of Nebraska
Guzo David
LandOfFree
Coxsackie virus as a vector for delivery of anti-inflammatory cy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Coxsackie virus as a vector for delivery of anti-inflammatory cy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Coxsackie virus as a vector for delivery of anti-inflammatory cy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2212240